Hospital
Palo Pinto County Hospital District
Palo Pinto County Hospital District was paid $1.82M by Medicaid between Oct 2020 and Dec 2024, across 60 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoPALO PINTO COUNTY HOSPITAL DISTRICT
MINERAL WELLS, TX 76067
MINERAL WELLS, TX 76067
33aNPI1972590602assigned 09/27/2005
33bProvider typeRural Acute Care Hospital
28Total paid$1.82M
24GClaims41,519
24DCodes billed60
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in Texas
Rank by total paid#4 of 11
Median peer was paid$1.32M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 800 | $49K | |
| 2021 | 11,254 | $468K | |
| 2022 | 13,614 | $548K | |
| 2023 | 10,871 | $545K | |
| 2024incomplete | 4,980 | $209K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 4,749 | 4,570 | $597K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 2,668 | 2,481 | $537K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12% | 2,729 | 2,662 | $225K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.1% | 4,168 | 3,913 | $74K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.0% | 219 | 206 | $72K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 663 | 653 | $32K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 681 | 640 | $32K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 444 | 435 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,579 | 1,187 | $26K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.3% | 187 | 175 | $24K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 477 | 472 | $23K |
| 81025 | 1.2% | 2,308 | 2,135 | $23K |
48 more codes
| 80053 | Comprehensive metabolic panel | 1.2% | 3,247 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,482 | $16K |
| 81002 | <1% | 3,159 | $13K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 115 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 885 | $7K |
| 87581 | <1% | 219 | $6K | |
| 87486 | <1% | 219 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 36 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 83 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 336 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 227 | $4K |
| 59025 | Fetal non-stress test | <1% | 30 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 463 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 285 | $3K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 29 | $2K |
| 99285 | Emergency room visit (most serious) | <1% | 14 | $2K |
| 81001 | <1% | 1,075 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 448 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 265 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 45 | $2K |
| 87070 | <1% | 153 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,629 | $630.72 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 235 | $567.57 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 153 | $433.35 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 75 | $412.21 |
| 84484 | <1% | 218 | $277.97 | |
| 83690 | <1% | 168 | $246.16 | |
| 83880 | <1% | 73 | $240.28 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 105 | $192.70 |
| 83655 | <1% | 12 | $183.65 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 302 | $180.82 |
| 85018 | <1% | 37 | $123.09 | |
| 80061 | Lipid panel | <1% | 63 | $106.08 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 91 | $75.74 |
| 85027 | <1% | 15 | $59.01 | |
| 85610 | <1% | 31 | $46.32 | |
| 85007 | <1% | 15 | $34.12 | |
| 85730 | <1% | 15 | $28.85 | |
| 82550 | <1% | 23 | $21.88 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $16.32 |
| 81003 | <1% | 14 | $12.69 | |
| 83605 | <1% | 15 | $9.72 | |
| 87186 | <1% | 15 | $7.27 | |
| 90670 | <1% | 284 | $1.17 | |
| 90688 | <1% | 112 | $0.38 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 95 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSELSOR, DOUGLAS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Palo Pinto County Hospital District | Mineral Wells, TX | $2.44M |
| Palo Pinto County Hospital District | Mineral Wells, TX | $16K |
| Palo Pinto County Hospital District | Mineral Wells, TX | $12K |
| Palo Pinto County Hospital District | Santo, TX | $10K |
| Palo Pinto County Hospital District | Mineral Wells, TX | $5K |
| Palo Pinto County Hospital District | Mineral Wells, TX | $5K |
| Palo Pinto County Hospital District | Mineral Wells, TX | $3K |
| Palo Pinto County Hospital District | Gordon, TX | $2K |
| Palo Pinto County Hospital District | Mineral Wells, TX | $79.53 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.